Jonathan Roy, a Director at the Cannabis Investor Forum, said the U.K. investment opportunities are currently limited to a few companies as others ‘play a waiting game’.
Speaking at the recent Hemp & CBD Expo in Birmingham, England, Mr Roy said its research indicates there are companies looking to list on the London financial exchanges, but want others to take the plunge first.
He said: “There are cannabis companies looking to float on the London markets, some just do not want to be the first, as the costs will be high. However, once the market starts to move we expect to see 10 to 15 companies listing, within two years, and the creation of a recognized cannabis sector on the market.
“While we are currently seeing North American companies attracted to Frankfurt it does not match the financial liquidity available in London, and it will develop as the primary European market.”
While North American companies are attracting the interest of leading global brands – Hexo and Molson Coors, Canopy and Constellation – these type of deals will not be evident in London for some time, said Mr Roy.
“We are still at a very, very, early stage, for companies in the U.K. and it may be a further three years before they become the targets for the major brands.”
One of the issues facing U.K. cannabis businesses is the Proceeds of Crime Act which deters investment, with banks being wary of any potential legal pitfalls, and reticent to invest.
Nick Tulloch, CEO of Zoetic, formerly Highlands Natural Resources, heads one of the few U.K. companies currently listed on the London Markets. He says these concerns and ‘confusion’ around regulations, are making conservative, institutional investors wary of the sector
“They don’t want any scandals, so at the moment the money is coming from smaller retail investors, some smaller, fleet-footed institutions and high net-worth families. I can speak to three different lawyers and get three different opinions. Harmonisation, and a clear regulatory structure would be very welcome, and would and create certainty to deal with some of the issues with the banks.”
He said the influence of social media is key in the cannabis space saying investors ask first about packaging and social media presence, before moving on to the quality of the product.
Geoff Miller, of specialist cannabis financial advisors Cannafi, said most family, high net-worth offices now have an investment in the sector. “Lots of institutional investors cannot see anything in there, large enough to get involved, but they are keeping an eye, and will eventually come in.”
The inability of the banks to embrace the cannabis industry over regulatory and legal concerns means many cannabis businesses are forced to use virtual providers at costly premium, he explained. A number of cannabis company’s currently trade on smaller markets in London, such as the NEX Exchange, including The Sativa Group and Ananda Developments.
The London Stock Exchange is expected to get its first listing with Israeli firm Kanabo Research and Australian firm MGC Pharmaceuticals company both looking to float in the coming months.
The post London To Replace Frankfurt As Europe’s Cannabis Capital Hub appeared first on Cannadelics.
Nov. 8, Missouri residents will have the opportunity to vote on legalization of adult-use cannabis. Missouri passed a constitutional amendment for medical cannabis in 2018 and advocates are looking to build on the momentum in the state. Amendment 3, the Marijuana Legalization Initiative, is on the ballot in Missouri as an initiated constitutional amendment. If […]
A link to your site, with your site's name and description as anchor text.
They’re not there yet, and they might not get there, but this coming November, at least three states, (and possibly six), are putting it up to voters in yet more cannabis ballot measures for recreational legalizations. Will we get up to 25 legal states by the end of elections? 2022 elections are going to be […]
The post 2022 Cannabis Ballot Measures: Up to Six States Voting for Recreational appeared first on Cannadelics.